One-Stage Assay May Underestimate Bleeding Risk After Gene Therapy in Hemophilia A Patients
A recent study highlighted in Hematology Advisor explores the challenges of monitoring patients with hemophilia A after gene therapy, specifically focusing on the reliability of laboratory assays used to measure…